• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺激素样蛋白(1 - 141)编码基因的合成:表达蛋白的纯化及生物学特性分析

Synthesis of a gene encoding parathyroid hormone-like protein-(1-141): purification and biological characterization of the expressed protein.

作者信息

Thorikay M, Kramer S, Reynolds F H, Sorvillo J M, Doescher L, Wu T, Morris C A, Burtis W J, Insogna K L, Valenzuela D M

机构信息

Oncogene Science, Inc., Manhasset, New York 11030.

出版信息

Endocrinology. 1989 Jan;124(1):111-8. doi: 10.1210/endo-124-1-111.

DOI:10.1210/endo-124-1-111
PMID:2535801
Abstract

PTH-like proteins (PTHLP), which are associated with humoral hypercalcemia of malignancy, have recently been purified. Isolation of their corresponding cDNAs has revealed that they are derived from a single gene. In this report a synthetic gene encoding PTHLP-(1-141), a 141-amino acid protein corresponding to the most abundant PTHLP cDNA detected in human tumors, was expressed in bacteria and purified to homogeneity. Recombinant (r) PTHLP-(1-141) migrates with an aberrantly high mol wt on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, presumably as a result of its unusually basic pI. rPTHLP-(1-141), like PTH, induced hypercalcemia in rats, caused release of 45Ca from fetal rat bones, and stimulated the synthesis of cAMP by rat osteosarcoma cells and canine renal membrane preparations. A comparison of the abilities of rPTHLP-(1-141) and bovine PTH-(1-34) to stimulate cAMP synthesis indicated rPTHLP-(1-141) to be 5-fold more potent in the osteosarcoma assay, while nearly 30-fold less active in the renal membrane adenylate cyclase assay. Although 100-fold less potent than bovine PTH-(1-34) in promoting bone resorption, rPTHLP-(1-141) was a potent calcemic factor in vivo, inducing a rise in serum calcium from 10.4 to 14.5 mg/dl when infused into rats at 1.3 micrograms/h. These results support previous assumptions that PTHLP is the humoral factor responsible for humoral hypercalcemia of malignancy. In addition, they suggest substantial differences between PTHLP and PTH in the regulation of calcium homeostasis.

摘要

与恶性肿瘤体液性高钙血症相关的甲状旁腺激素样蛋白(PTHLP)最近已被纯化。其相应cDNA的分离表明它们源自单个基因。在本报告中,编码PTHLP-(1-141)的合成基因在细菌中表达并纯化至同质,PTHLP-(1-141)是一种141个氨基酸的蛋白质,对应于在人类肿瘤中检测到的最丰富的PTHLP cDNA。重组(r)PTHLP-(1-141)在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上以异常高的分子量迁移,推测是由于其异常碱性的pI。rPTHLP-(1-141)与甲状旁腺激素(PTH)一样,可诱导大鼠高钙血症,导致胎鼠骨骼释放45Ca,并刺激大鼠骨肉瘤细胞和犬肾膜制剂合成环磷酸腺苷(cAMP)。rPTHLP-(1-141)和牛PTH-(1-34)刺激cAMP合成能力的比较表明,rPTHLP-(1-141)在骨肉瘤试验中的效力高5倍,而在肾膜腺苷酸环化酶试验中的活性低近30倍。尽管rPTHLP-(1-141)在促进骨吸收方面的效力比牛PTH-(1-34)低100倍,但它在体内是一种有效的血钙因子,以1.3微克/小时的速度注入大鼠时,可使血清钙从10.4毫克/分升升至14.5毫克/分升。这些结果支持了先前的假设,即PTHLP是导致恶性肿瘤体液性高钙血症的体液因子。此外,它们表明PTHLP和PTH在钙稳态调节方面存在实质性差异。

相似文献

1
Synthesis of a gene encoding parathyroid hormone-like protein-(1-141): purification and biological characterization of the expressed protein.甲状旁腺激素样蛋白(1 - 141)编码基因的合成:表达蛋白的纯化及生物学特性分析
Endocrinology. 1989 Jan;124(1):111-8. doi: 10.1210/endo-124-1-111.
2
Synthetic parathyroid hormone-like protein-(1-74): biochemical and physiological characterization.合成甲状旁腺激素样蛋白 -(1 - 74):生化与生理学特性
Endocrinology. 1989 Feb;124(2):642-8. doi: 10.1210/endo-124-2-642.
3
Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34.甲状旁腺激素相关蛋白(PTHrP)1-34和甲状旁腺激素(PTH)1-34对大鼠骨细胞和肾细胞中环磷酸腺苷(cAMP)形成的刺激作用相同。
Exp Clin Endocrinol. 1993;101(3):150-5. doi: 10.1055/s-0029-1211222.
4
Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats.合成的人甲状旁腺激素样蛋白可刺激大鼠的骨吸收并导致高钙血症。
J Clin Invest. 1988 Feb;81(2):596-600. doi: 10.1172/JCI113358.
5
Human parathyroid hormone (PTH)-related protein and human PTH: comparative biological activities on human bone cells and bone resorption.人甲状旁腺激素(PTH)相关蛋白与人PTH:对人骨细胞和骨吸收的比较生物学活性。
Endocrinology. 1988 Dec;123(6):2841-8. doi: 10.1210/endo-123-6-2841.
6
Quantitative evaluation of anticalciuretic effects of synthetic parathyroid hormonelike peptides.合成甲状旁腺激素样肽的抗利尿作用的定量评估。
J Bone Miner Res. 1990 Jun;5(6):653-8. doi: 10.1002/jbmr.5650050615.
7
Influence of the amino-terminus on in vitro and in vivo biological activity of synthetic parathyroid hormone-like peptides of malignancy.氨基末端对恶性肿瘤合成甲状旁腺激素样肽的体外和体内生物活性的影响。
Endocrinology. 1988 Dec;123(6):2709-16. doi: 10.1210/endo-123-6-2709.
8
Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo.甲状旁腺激素相关蛋白与白细胞介素-1α在体外协同刺激骨吸收,并在体内提高小鼠血清钙浓度。
Endocrinology. 1989 May;124(5):2172-8. doi: 10.1210/endo-124-5-2172.
9
The 7-34-fragment of human hypercalcemia factor is a partial agonist/antagonist for parathyroid hormone-stimulated cAMP production.人高钙血症因子的7 - 34片段是甲状旁腺激素刺激的环磷酸腺苷(cAMP)产生的部分激动剂/拮抗剂。
Endocrinology. 1988 Jun;122(6):3008-10. doi: 10.1210/endo-122-6-3008.
10
Bioactivity of parathyroid hormone and parathyroid hormone-like peptide: agonist and antagonist activities of amino-terminal fragments as assessed by the cytochemical bioassay and in situ biochemistry.甲状旁腺激素和甲状旁腺激素样肽的生物活性:通过细胞化学生物测定和原位生物化学评估氨基末端片段的激动剂和拮抗剂活性。
Endocrinology. 1991 Apr;128(4):1938-46. doi: 10.1210/endo-128-4-1938.

引用本文的文献

1
Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death.甲状旁腺激素相关肽的核仁定位在促进凋亡性细胞死亡的条件下可增强软骨细胞的存活能力。
Mol Cell Biol. 1995 Aug;15(8):4064-75. doi: 10.1128/MCB.15.8.4064.
2
Hypercalcaemia in malignancy.恶性肿瘤中的高钙血症
BMJ. 1989 Jun 3;298(6686):1468-9. doi: 10.1136/bmj.298.6686.1468.
3
Synthetic parathyroid hormone-like protein (1-74) is anabolic for bone in vivo.合成甲状旁腺激素样蛋白(1-74)在体内对骨骼具有合成代谢作用。
Calcif Tissue Int. 1992 Jul;51(1):30-4. doi: 10.1007/BF00296214.